MedPath

International Multicenter Prospective Transtar Registry

Completed
Conditions
Constipation
Interventions
Procedure: Stapled Transanal Rectal Resection with Contour Transtar
Registration Number
NCT00909116
Lead Sponsor
Ethicon Endo-Surgery (Europe) GmbH
Brief Summary

Obstructed Defecation Syndrome (ODS) describes a condition which is characterized by chronic constipation. The symptoms of ODS include abdominal pain or cramping, irregular bowel frequency and the feeling of not having emptied the rectum. ODS is usually associated with internal rectal prolapse and/or rectocele. For surgical treatment of ODS, a plethora of surgical techniques have been described with no one method having been assessed as a gold standard.

Detailed Description

A new surgical procedure - Transtar - has been introduced in Europe recently. The goal of this registry is to assess safety, effectiveness and patient quality of life, associated with Transtar for chronic constipation due to morphological changes, such as internal rectal prolapse and rectocele.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Patients with obstructed defecation, fragmented defecation or incomplete evacuation as a presenting symptom documented by a standardized symptom score
  • confirmed internal rectal prolapse or rectocele on dynamic defecography
  • adequate external sphincter on rectal digital examination.
Exclusion Criteria
  • Subjects with any other surgical procedure than STARR for ODS
  • Subjects in whom STARR is not performed with the Contour Transtar stapler
  • Subjects with a physical or psychological condition which would impair participation in the registry.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Chronic constipation - ODSStapled Transanal Rectal Resection with Contour TranstarAdult Patients with ODS
Primary Outcome Measures
NameTimeMethod
Change in constipation symptoms measured by KESS scorepreoperative, and at 12 months post-op
Secondary Outcome Measures
NameTimeMethod
Changes in patients symptoms measured by Incontinence score and ODS Score, QoL measures with EQ5D and PAC-QoLpreoperative, at 6 weeks and 12 months post-op

Trial Locations

Locations (1)

Andree D'Hoore

🇧🇪

Leuven, Belgium

© Copyright 2025. All Rights Reserved by MedPath